Cyrano Therapeutics, a clinical-stage regenerative medicine company pioneering the development of treatments for smell loss, and Resyca, a leading innovator in soft mist inhaler and soft nasal spray ...

Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results ... administration 70-mg repeat-dose regimen, of etripamil nasal spray, outside of the medically supervised setting, similar ...

Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. It develops ...